Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment

Nik, M. E. and Momtazi-Borojeni, A. A. and Zamani, P. and Navashenaq, J. G. and Iranshahi, M. and Jaafari, M. R. and Malaekeh-Nikouei, B. (2019) Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. Journal of Cellular Physiology, 234 (9). pp. 14721-14733.

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/abs/10.1002/jc...
Item Type: Article
Additional Information: Cited By :2 Export Date: 7 July 2020
Subjects: QV pharmacology
QZ pathology-neoplasms-Genetics
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib5 lib5
Date Deposited: 05 Aug 2020 04:34
Last Modified: 05 Aug 2020 04:34
URI: http://eprints.mums.ac.ir/id/eprint/22517

Actions (login required)

View Item View Item